Literature DB >> 20720565

FcγRIIA and FcγRIIIB are required for autoantibody-induced tissue damage in experimental human models of bullous pemphigoid.

Xinhua Yu, Karoline Holdorf, Brigitte Kasper, Detlef Zillikens, Ralf J Ludwig, Frank Petersen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20720565     DOI： 10.1038/jid.2010.230

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  11 in total

Review 1.  Mechanisms of Autoantibody-Induced Pathology.

Authors:  Ralf J Ludwig; Karen Vanhoorelbeke; Frank Leypoldt; Ziya Kaya; Katja Bieber; Sandra M McLachlan; Lars Komorowski; Jie Luo; Otavio Cabral-Marques; Christoph M Hammers; Jon M Lindstrom; Peter Lamprecht; Andrea Fischer; Gabriela Riemekasten; Claudia Tersteeg; Peter Sondermann; Basil Rapoport; Klaus-Peter Wandinger; Christian Probst; Asmaa El Beidaq; Enno Schmidt; Alan Verkman; Rudolf A Manz; Falk Nimmerjahn
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

2.  Human neutrophils express low levels of FcγRIIIA, which plays a role in PMN activation.

Authors:  Josée Golay; Rut Valgardsdottir; Gerta Musaraj; Damiano Giupponi; Orietta Spinelli; Martino Introna
Journal:  Blood       Date:  2019-01-17       Impact factor: 22.113

3.  Prevalence of pemphigus and pemphigoid autoantibodies in the general population.

Authors:  Wiebke Prüßmann; Jasper Prüßmann; Hiroshi Koga; Andreas Recke; Hiroaki Iwata; David Juhl; Siegfried Görg; Reinhard Henschler; Takashi Hashimoto; Enno Schmidt; Detlef Zillikens; Saleh M Ibrahim; Ralf J Ludwig
Journal:  Orphanet J Rare Dis       Date:  2015-05-15       Impact factor: 4.123

4.  Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita.

Authors:  Ralf J Ludwig
Journal:  ISRN Dermatol       Date:  2013-07-15

5.  EndoS reduces the pathogenicity of anti-mCOL7 IgG through reduced binding of immune complexes to neutrophils.

Authors:  Xinhua Yu; Junfeng Zheng; Mattias Collin; Enno Schmidt; Detlef Zillikens; Frank Petersen
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

6.  Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2.

Authors:  Christian M Karsten; Tina Beckmann; Maike M Holtsche; Jenny Tillmann; Sabrina Tofern; Franziska S Schulze; Eva Nina Heppe; Ralf J Ludwig; Detlef Zillikens; Inke R König; Jörg Köhl; Enno Schmidt
Journal:  Front Immunol       Date:  2018-03-15       Impact factor: 7.561

7.  Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita.

Authors:  Hiroshi Koga; Anika Kasprick; Rosa López; Mariona Aulí; Mercè Pont; Núria Godessart; Detlef Zillikens; Katja Bieber; Ralf J Ludwig; Cristina Balagué
Journal:  Front Immunol       Date:  2018-07-12       Impact factor: 7.561

Review 8.  Resolution in bullous pemphigoid.

Authors:  Christian D Sadik; Enno Schmidt
Journal:  Semin Immunopathol       Date:  2019-11-15       Impact factor: 9.623

9.  Visualization of autoantibodies and neutrophils in vivo identifies novel checkpoints in autoantibody-induced tissue injury.

Authors:  Jennifer E Hundt; Hiroaki Iwata; Mario Pieper; Peter König; Ralf J Ludwig; Rebecca Pfündl; Katja Bieber; Detlef Zillikens
Journal:  Sci Rep       Date:  2020-03-11       Impact factor: 4.379

Review 10.  Epidermolysis Bullosa Acquisita: The 2019 Update.

Authors:  Hiroshi Koga; Catherine Prost-Squarcioni; Hiroaki Iwata; Marcel F Jonkman; Ralf J Ludwig; Katja Bieber
Journal:  Front Med (Lausanne)       Date:  2019-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.